Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
11/18/1999 | CA2331998A1 Novel spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and ap-1 inhibitors containing the same |
11/18/1999 | CA2331118A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
11/18/1999 | CA2330623A1 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia |
11/18/1999 | CA2330557A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
11/18/1999 | CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
11/17/1999 | EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
11/17/1999 | EP0957101A1 Water soluble azoles as broad-spectrum antifungals |
11/17/1999 | EP0957100A1 Diamine derivatives and pharmaceutical containing the same |
11/17/1999 | EP0956287A1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function |
11/17/1999 | EP0741695B1 Hydroxamic-acid derivatives, method of preparing them and their use as fungicides |
11/17/1999 | CN1235610A Peptide derivatives having thiazolyl-alanine residue |
11/17/1999 | CN1235603A N-substituted azaheterocyclic compounds |
11/16/1999 | US5986075 Coupling a desalted organic diazonium compound with a coupling compound |
11/16/1999 | US5985905 Useful for the treatment and/or prophylaxis of diseases associated with loss of bone mass, such as osteoporosis and related osteopenic diseases, paget's disease, hyperparathyroidism and related diseases, also antitumor |
11/16/1999 | US5985903 Microbicidal benzotriazoles |
11/16/1999 | US5985884 Treatment and/or prophylaxis of diseases or conditions in which insulin resistance is the underlying pathophysiological mechanism such as type ii diabetes, impaired glucose tolerance, dyslipidaemia, hypertension, coronary heart disease |
11/16/1999 | US5985879 Compounds useful for inhibition of farnesyl protein transferase |
11/16/1999 | US5985878 Angiogenesis inhibiting pyridazinamines |
11/16/1999 | US5985872 2-amino-benzoxazinones for the treatment of viral infections |
11/16/1999 | US5985869 Benzoheterocyclic compounds |
11/16/1999 | US5985867 Treating hiv infection |
11/16/1999 | US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar |
11/16/1999 | CA2064815C Therapeutic heterocyclic compounds |
11/16/1999 | CA2013599C Aryl-substituted rhodanine derivatives |
11/16/1999 | CA2002864C (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
11/11/1999 | WO1999057124A1 Monomeric, oligomeric and polymeric knoevenagel condensation products |
11/11/1999 | WO1999057122A1 3-phenylpyrrole alpha-1 adrenergic compounds |
11/11/1999 | WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
11/11/1999 | WO1999057113A1 Heterocyclic derivatives which inhibit factor xa |
11/11/1999 | WO1998004528A3 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
11/11/1999 | CA2331042A1 Heterocyclic derivatives which inhibit factor xa |
11/11/1999 | CA2330811A1 Monomeric, oligomeric and polymeric knoevenagel condensation products |
11/11/1999 | CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments |
11/10/1999 | EP0955294A2 Imidazolyl-alkenoic acid |
11/10/1999 | EP0954526A2 Serine protease inhibitors |
11/10/1999 | EP0740666B1 Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines |
11/10/1999 | CN1234798A Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants |
11/10/1999 | CN1234795A Heterocyclic esters and amides chemical compounds |
11/10/1999 | CN1234400A Oxodiethylenediamine derivative and light stabilized composition |
11/10/1999 | CN1234397A Compounds of carbostyrils and their preparation and use |
11/10/1999 | CN1046276C Easters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones and use thereof |
11/10/1999 | CN1046275C 2-methoxyaminophenyl-N-methyl acet amides derivatives, preparing method, use and composition containing same |
11/10/1999 | CN1046274C Isoxazoline compounds as antinflammatory agents |
11/10/1999 | CN1046269C HIV protease inhibitors |
11/09/1999 | US5981755 Tachykinin antagonists |
11/09/1999 | US5981748 Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates |
11/09/1999 | US5981576 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
11/09/1999 | US5981570 Benzothiophene compounds, compositions, and methods |
11/09/1999 | US5981559 Azole derivative with leukotriene (LTs) antagonizing activity and thromboxane (TX) A2 antagonizing activity |
11/09/1999 | US5981557 Aminothiazole derivative, medicament containing the same, and intermediate for preparation of said compound |
11/09/1999 | US5981547 Homochroman derivatives and related compounds useful as anti-inflammatory agents |
11/09/1999 | US5981525 Indole derivatives useful in the treatment of osteoporosis |
11/09/1999 | US5981519 Useful for treatment and prophylaxis of infectious diseases, especially those caused by methicillin resistant staphylococcus aureus and pseudomonas aeruginosa |
11/09/1999 | CA2133765C Cyclic-substituted unsymmetrical cyanine dyes |
11/04/1999 | WO1999055702A1 Substituted (4-brompyrazole-3-yl)benzazoles |
11/04/1999 | WO1999055696A1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
11/04/1999 | WO1999055682A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists |
11/04/1999 | WO1999055681A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
11/04/1999 | WO1999055676A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
11/04/1999 | WO1999055318A1 Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases |
11/04/1999 | WO1999055156A2 The use of derivatives of iminotriazole as crop protection agents and novel iminotriazoles |
11/04/1999 | WO1999031074A3 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
11/04/1999 | CA2330458A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists |
11/04/1999 | CA2330304A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
11/04/1999 | CA2329873A1 Substituted (4-brompyrazole-3-yl)benzazoles |
11/03/1999 | EP0953355A1 Remedy for autoimmune diseases |
11/03/1999 | EP0952832A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors |
11/03/1999 | CN1234035A Sulfonyl benzazolones |
11/03/1999 | CN1234028A Substd. benzoylaminothiazole derivatives and drugs containing same |
11/03/1999 | CN1234027A Oxime derivatives and their use as fungicides |
11/03/1999 | CN1234026A Piperazino derivatives as neurokinin antagonists |
11/03/1999 | CN1233957A Pharmaceutical compositions |
11/02/1999 | USRE36375 Treatment of Alzheimer's disease using azacyclic compounds |
11/02/1999 | USRE36374 1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists |
11/02/1999 | US5977384 Benzothiazolone derivatives |
11/02/1999 | US5977373 Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents |
11/02/1999 | US5977365 Heterocyclic compound having anti-diabetic activity |
11/02/1999 | US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present |
11/02/1999 | US5977344 Dna analysis kit with intercalating fluorescent multimers; for detection of dna in electrophoresis and probes with high fluorescent efficiencies and large stokes shifts; can use single narrow wavelength band for excitation |
11/02/1999 | US5977169 Substituted tetronic acids useful for treating HIV and other retroviruses |
11/02/1999 | US5977167 Benzopyran and benzoxazine derivatives |
11/02/1999 | US5977154 Obesity, diabetes |
11/02/1999 | US5977149 Dihydrotriazole compounds and their use for controlling fungal plant diseases |
11/02/1999 | US5977146 Pyridylcarbamates, process and intermediates for their preparation, and their use |
11/02/1999 | US5977142 Oxa-and thia-diazole muscarinic receptor antagonists |
11/02/1999 | US5977140 N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds and their therapeutic utility |
11/02/1999 | US5977137 Sulfonamide inhibitors of aspartyl protease |
11/02/1999 | US5977129 Alzheimer's disease |
11/02/1999 | US5977113 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility |
11/02/1999 | US5977110 Substituted cyclohexylamines as central nervous systems agents |
11/02/1999 | US5977108 Leukemia |
11/02/1999 | US5977105 Compounds |
11/02/1999 | US5977101 Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
11/02/1999 | US5977027 Pyrimidone isobutyric acid and herbicides containing the same |
10/28/1999 | WO1999054330A1 2,3-olefinic epothilone derivatives |
10/28/1999 | WO1999054329A1 Novel 2-heterocyclically substituted dihydropyrimidines |
10/28/1999 | WO1999054326A1 Dihydropyrimidines |
10/28/1999 | WO1999054319A1 12,13-modified epothilone derivatives |
10/28/1999 | WO1999054318A1 12,13-cyclopropane epothilone derivatives |
10/28/1999 | WO1999054312A1 The use of dihydropyrimidines as medicaments, and novel substances |